Related Experiment Video
Updated: Jul 6, 2026
09:59
GABA-activated Single-channel and Tonic Currents in Rat Brain Slices
Published on: July 17, 2011
Modafinil modulates GABA-activated currents in rat hippocampal pyramidal neurons
Qing Huang1, Ling Zhang, Hui Tang
1College of Stomatology, Anhui Medical University, Hefei 230032, China.
Brain Research
|April 9, 2008
Summary
Modafinil, used for narcolepsy and other conditions, reduces GABA-activated currents. This effect is mediated by ATP-sensitive potassium channels (K(ATP)), suggesting a new therapeutic mechanism.
Area of Science:
- Neuropharmacology
- Channel physiology
Background:
- Modafinil is a psychoactive drug treating narcolepsy, hypoglycemia, cerebral ischemia, and Parkinson's disease.
- ATP-sensitive potassium channels (K(ATP)) are crucial in cellular responses to ischemia, hypoglycemia, and metabolic inhibition.
Purpose of the Study:
- To investigate the effect of modafinil on GABA-activated currents.
- To determine the role of K(ATP) channels in modafinil's action on GABA currents.
Main Methods:
- Electrophysiological recordings of GABA-activated currents in neurons.
- Dose-dependent application of modafinil (0.01-1 mM).
- Pretreatment with the K(ATP) channel blocker, glibenclamide (10 microM).
Main Results:
- Modafinil dose-dependently decreased GABA-activated currents.
- Glibenclamide pretreatment significantly attenuated the modafinil-induced decrease in GABA currents.
- This indicates an indirect inhibitory effect of modafinil on GABA currents.
Conclusions:
- Modafinil's inhibitory effect on GABA-activated currents is, at least in part, mediated by the modulation of K(ATP) channel activation.
- This finding provides insight into the neuropharmacological mechanisms of modafinil.
Related Concept Videos
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...